P118 ALTTO (adjuvant lapatinib and/or trastuzumab treatment optimisation) study [BIG 2-06/N063D/EGF106708]: a phase III study for HER2-overexpressing early breast cancer (BC)

✍ Scribed by M.J. Piccart-Gebhart; E.A. Perez; J. Baselga; R.D. Gelber; D. Rosa; E. Azambuja; C. Oliva; A. Goldhirsch

• Book ID: 114316031
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 58 KB
• Volume: 16
• Category: Article
• ISSN: 0960-9776
• DOI: 10.1016/s0960-9776(07)70178-9